• Kaufman DW, Kelly JP, Issaragrisil S, Laporte JR, Anderson T, Levy M, Shapiro S, Young NS. Relative incidence of Agranulocytosis and aplastic anemia. Am J Hematol 2006;81(1):65-7.

• Siskind V, Kelly JP, Kaufman DW. Estimating risks for matching factors in case-control studies. J Clin Epidemiol 2000;53:251-6.

• Wiholm B-E, Kelly JP, Kaufman DW, Issaragrisil S, Levy M, Anderson T, Shapiro S. Relation of aplastic anaemia to use of chloramphenicol eye drops in two international case-control studies. BMJ 1998;316:666.

• Kaufman DW, Kelly JP, Jurgelon JM, Anderson T, Issaragrisil S, Wiholm B-E, Young NS, Leaverton P, Levy M, Shapiro S. Drugs in the aetiology of agranulocytosis and aplastic anemia. Eur J Haematol 1996;57(suppl):23-30.

• Kelly JP, Jurgelon JM, Issaragrisil S, Keisu M, Kaufman DW. An epidemiologic study of aplastic anemia: relationship of drug exposures to clinical features and outcome. Eur J Haematol 1996;57(suppl):47-52.

• Shapiro S. L-trytophan and eosinophilia-myalgia syndrome. [Letter to the Editor] Lancet 1994;343:1035.

• Kaufman DW. Risk/benefit consideration in the use of analgesics. In: Gerber WD, Nappi G, editors. Update on Non-Narcotic Analgesic Research. Fiuggi , Italy , October 2-3, 1992. Basel: Birkhäuser Verlag, 1993:91-100.

• Kaufman DW, Kelly JP, Levy M, Shapiro S. Risk evaluation of antipyretic analgesics. II. New results from ongoing studies. In: Brune K, ed. New Clinical and Epidemiological Data on Dipyrone. Yokohama , Japan . July 28th, 1992 . Basel: Birkhäuser Verlag, 1993:39-52.

• Kaufman DW, Kelly JP, Levy M, Shapiro S. The drug etiology of agranulocytosis: An update of the International Agranulocytosis and Aplastic Anemia Study. Pharmacoepidemiol Drug Saf 1993;2:S25-S29.

• Kelly JP, Kaufman DW, Shapiro S. Risks of agranulocytosis and aplastic anemia in relation to the use of cardiovascular drugs: The International Agranulocytosis and Aplastic Anemia Study. Clin Pharmacol Ther 1991;49:330-41.

• Keisu M, Heit W, Lambertenghi-Deliliers G, Parcells-Kelly J, Polliack A, Heimpel H. Transient pancytopenia: A report from the International Agranulocytosis and Aplastic Study. Blut 1990;61:240-4.

• International Agranulocytosis and Aplastic Anemia Study. Anti-infective drug use in relation to the risk of agranulocytosis and aplastic anemia. Arch Intern Med 1989;149:1036-40.

• International Agranulocytosis and Aplastic Anemia Study. Risk of agranulocytosis and aplastic anemia in relation to use of antithyroid drugs. BMJ 1988;297:262-5.

• The International Agranulocytosis and Aplastic Anemia Study. Incidence of aplastic anemia: The relevance of diagnostic criteria. Blood 1987;70:1718-21.

• The International Agranulocytosis and Aplastic Anemia Study. Risks of agranulocytosis and aplastic anemia: A first report of their relation to drug use with special reference to analgesics. JAMA 1986;256:1749-57.

• International Agranulocytosis and Aplastic Anemia Study. The design of a study of the drug etiology of agranulocytosis and aplastic anemia: A report from the International Agranulocytosis and Aplastic Anemia Study. Eur J Clin Pharmacol 1983;24:833-6.

Books

• Kaufman DW, Kelly JP, Levy M, Shapiro S. The Drug Etiology of Agranulocytosis and Aplastic Anemia: The International Agranulocytosis and Aplastic Anemia Study. New York : Oxford University Press, 1991.